Webster Bank’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-120
| Closed | -$22K | – | 560 |
|
|
2021
Q2 | $22K | Hold |
120
| – | – | ﹤0.01% | 398 |
|
|
2021
Q1 | $18K | Hold |
120
| – | – | ﹤0.01% | 432 |
|
|
2020
Q4 | $19K | Hold |
120
| – | – | ﹤0.01% | 410 |
|
|
2020
Q3 | $14K | Hold |
120
| – | – | ﹤0.01% | 406 |
|
|
2020
Q2 | $13K | Hold |
120
| – | – | ﹤0.01% | 402 |
|
|
2020
Q1 | $11K | Sell |
120
-5,000
| -98% | -$458K | ﹤0.01% | 403 |
|
|
2019
Q4 | $554K | Buy |
5,120
+5,000
| +4,167% | +$541K | 0.07% | 143 |
|
|
2019
Q3 | $12K | Hold |
120
| – | – | ﹤0.01% | 430 |
|
|
2019
Q2 | $16K | Hold |
120
| – | – | ﹤0.01% | 409 |
|
|
2019
Q1 | $16K | Hold |
120
| – | – | ﹤0.01% | 405 |
|
|
2018
Q4 | $12K | Hold |
120
| – | – | ﹤0.01% | 407 |
|
|
2018
Q3 | $17K | Sell |
120
-6,880
| -98% | -$975K | ﹤0.01% | 419 |
|
|
2018
Q2 | $869K | Hold |
7,000
| – | – | 0.13% | 123 |
|
|
2018
Q1 | $780K | Sell |
7,000
-3,000
| -30% | -$334K | 0.11% | 129 |
|
|
2017
Q4 | $1.2M | Hold |
10,000
| – | – | 0.16% | 120 |
|
|
2017
Q3 | $1.4M | Hold |
10,000
| – | – | 0.2% | 108 |
|
|
2017
Q2 | $1.22M | Buy |
10,000
+2,000
| +25% | +$243K | 0.18% | 113 |
|
|
2017
Q1 | $970K | Hold |
8,000
| – | – | 0.15% | 125 |
|
|
2016
Q4 | $979K | Buy |
8,000
+1,000
| +14% | +$122K | 0.14% | 121 |
|
|
2016
Q3 | $858K | Hold |
7,000
| – | – | 0.12% | 130 |
|
|
2016
Q2 | $817K | Buy |
7,000
+2,000
| +40% | +$233K | 0.12% | 126 |
|
|
2016
Q1 | $696K | Buy |
5,000
+3,000
| +150% | +$418K | 0.11% | 133 |
|
|
2015
Q4 | $382K | Hold |
2,000
| – | – | 0.06% | 154 |
|
|
2015
Q3 | $313K | Hold |
2,000
| – | – | 0.06% | 157 |
|
|
2015
Q2 | $362K | Buy |
+2,000
| New | +$362K | 0.06% | 153 |
|